Literature DB >> 33015779

Up-regulated ONECUT2 and down-regulated SST promote gastric cell migration, invasion, epithelial-mesenchymal transition and tumor growth in gastric cancer.

G-H Wang1, Y-M Zhou, Z Yu, J-P Deng, S-F Liu, C-Z Wei, Y Feng, M Mao, Z Wang.   

Abstract

OBJECTIVE: Gastric cancer is a common malignancy, with high metastasis and poor prognosis. Our purpose was to explore potential molecular mechanisms of gastric cancer. PATIENTS AND METHODS: A total of 10 pairs of gastric cancer tissues and adjacent normal gastric tissues were collected for RNA sequencing (RNA-seq), followed by differential expression analysis. Combining qRT-PCR results, two novel genes were selected for in-depth analysis, including up-regulated ONECUT and down-regulated SST. To investigate the effects of ONECUT and SST on the biological behaviors of gastric cancer cells, gastric cancer cell lines were transfected by ONECUT2 knockdown and SST overexpression. Afterwards, cell migration and invasion were examined using transwell assays, and the expressions of epithelial-mesenchymal transition (EMT)-related proteins were measured by Western blot analysis. Furthermore, cell viability was detected by CCK-8 assay. Finally, tumorigenicity in nude mice was performed.
RESULTS: Gastric cancer cell migration and invasion were inhibited in BGC823 cells transfected by shONECUT2. Similar results were observed in SST overexpression in MGC803 cells. Silencing ONECUT2 or overexpressing SST reduced the expressions of mesenchymal markers (N-cadherin and vimentin), STAT3, fibronectin, Wnt2, β-catenin and increased epithelial marker (E-cadherin), p-STAT3, smad2/3, α-catenin protein levels. In addition, inhibiting ONECUT2 or elevated SST suppressed tumor cell viability in vitro. Moreover, ONECUT2 silencing or elevated SST significantly inhibited tumor growth in vivo.
CONCLUSIONS: Up-regulated ONECUT2 and down-regulated SST promote gastric cell migration, invasion, epithelial-mesenchymal transition and tumor growth in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33015779     DOI: 10.26355/eurrev_202009_23021

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer.

Authors:  Luya Cai; Chuan Hu; Shanshan Yu; Lixiao Liu; Jinduo Zhao; Ye Zhao; Fan Lin; Xuedan Du; Qiongjie Yu; Qinqin Xiao
Journal:  Front Genet       Date:  2020-12-02       Impact factor: 4.599

2.  Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.

Authors:  Jinhui Liu; Guoliang Cui; Shuning Shen; Feng Gao; Hongjun Zhu; Yinghua Xu
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

3.  ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY.

Authors:  Danfei Liu; Tongyue Zhang; Xiaoping Chen; Bixiang Zhang; Yijun Wang; Meng Xie; Xiaoyu Ji; Mengyu Sun; Wenjie Huang; Limin Xia
Journal:  Cell Death Dis       Date:  2021-11-27       Impact factor: 8.469

4.  Site-Specific Hypermethylation of SST 1stExon as a Biomarker for Predicting the Risk of Gastrointestinal Tract Cancers.

Authors:  Xiantong Dai; Xin Sun; Ying Wu; Zhi Lv; Zhanwu Yu; Yuan Yuan; Liping Sun
Journal:  Dis Markers       Date:  2022-02-12       Impact factor: 3.434

5.  Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses.

Authors:  Qi-Yuan Lv; Hai-Zhou Zou; Yu-Yan Xu; Zhen-Yong Shao; Ruo-Qi Wu; Ke-Jie Li; Xia Deng; Dian-Na Gu; Hong-Xiao Jiang; Meng Su; Chang-Lin Zou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.